Dabigatran Etexilate: 9 recalls on record
Recalled by 1 agency: FDA (9).
First recall on record: April 5, 2023. Most recent: August 5, 2026.
Risk classification: Class II: 4 · Class III: 5
Most recent recalls
Questions about this brand
- How many recalls does Dabigatran Etexilate have?
- Recalert has 9 U.S. recalls on record for Dabigatran Etexilate, published between April 5, 2023 and August 5, 2026.
- What was the most recent Dabigatran Etexilate recall?
- FDA recall D-0738-2026, published August 5, 2026: Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS…
- Which agencies have recalled Dabigatran Etexilate products?
- Dabigatran Etexilate products appear in recalls from: FDA (9).
Do you sell Dabigatran Etexilate products? Check your whole catalog free against 80,000+ recalls.
Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.
Check my catalog freeWant it checked every night instead? Starter watches 500 SKUs for $29/month. See plans
Related brands
- Levothyroxine SodiumFDA · Food and drugs
- Sodium ChlorideFDA · Food and drugs
- DaytranaFDA · Food and drugs
- Atorvastatin CalciumFDA · Food and drugs
- DuloxetineFDA · Food and drugs
- LevoxylFDA · Food and drugs
- Chloraprep ONE-StepFDA · Food and drugs
- Chlorpromazine HydrochlorideFDA · Food and drugs
- Losartan PotassiumFDA · Food and drugs
- Metformin HydrochlorideFDA · Food and drugs